Form 4: Medpace Holdings Executive Exercises Stock Options

Medpace Holdings Executive Vice President, Operations, Susan E. Burwig, exercised stock options for 7,500 shares at $32.05 per share on November 19, 2024.

Summary

• Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc., exercised stock options on November 19, 2024.
• She acquired 7,500 shares of common stock at a price of $32.05 per share.
• This transaction increased her direct holdings to 65,000 shares of common stock.
• The stock options were granted previously and vested on February 28, 2022.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction, not indicative of any significant positive or negative sentiment. It's a standard part of executive compensation.

Positives

• The exercise of stock options by an executive can be seen as a positive sign of confidence in the company's future performance.

Industry Context

This is a routine transaction for a company that uses stock options as part of its executive compensation package. It is common for executives to exercise options as they vest.

Comparison to Industry Standards

• Stock option exercises are a standard part of executive compensation packages in publicly traded companies, particularly in the healthcare and pharmaceutical sectors where Medpace operates.
• Companies like IQVIA and Syneos Health also use stock options as part of their compensation strategy.
• The exercise price of $32.05 is specific to the terms of the options granted to Ms. Burwig and would be compared to the market price of the stock at the time of the grant and vesting.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it slightly increases the number of outstanding shares.

Key Dates

Keywords

stock options, insider trading, executive compensation, Medpace Holdings, equity, SEC Form 4